![]()
insidermonkey | 12 Most Promising Stocks to Buy According to Hedge Funds |
fool | Why BridgeBio Pharma Was a Healthy Stock Today |
investors | Pfizer Was First In Treating This Heart Disease. Why BridgeBio Could Be Better. |
insidermonkey | 15 Best Performing Stocks in the Last 6 Months |
gurufocus | Andreas Halvorsen's Q2 2023 13F Filing Update |
investors | BridgeBio Launches 64% Higher, Pulling Alnylam And Ionis With It, On A 'Best-Case' In Heart Disease |
fool | 2 Growth Stocks With Major Incoming Catalysts |
yahoo | Rare Disease Player BridgeBio Pharma Draws Attention Of Big Pharma Companies, Gets Takeover Interest |
fool | These 2 Biotech Stocks Made Big Monday Moves |
benzinga | BridgeBio's Dwarfism Candidate Shows Favorable Height Increase, Safety Profile |
fool | Why BridgeBio Pharma Stock Is Skyrocketing Today |
barrons | BridgeBio Stock Surges on Positive Dwarfism Drug Data. It’s Bad News for BioMarin. |
investors | BridgeBio Soars 64% And Breaks Out After Smashing Expectations In A Dwarfism Study |
yahoo | BridgeBio Pharma Highlights its RAS Precision Oncology Portfolio and Shares Compelling Data from Next-generation G12C Inhibitor and Novel PI3Kα:RAS Breaker Mechanism at the Fourth RAS Initiative Symposium - Yahoo Finance |
yahoo | BridgeBio Pharma Presents 12-month Results from Phase 2 Study of BBP-418 in Limb-Girdle Muscular Dystrophy Type 2i - Yahoo Finance |
yahoo | BridgeBio Pharma Announces First Lung Cancer Patient Dosed in Phase 1/2 Trial and US FDA Fast Track Designation for SHP2 inhibitor BBP-398 in Combination with Amgen’s LUMAKRAS® - Yahoo Finance |
yahoo | BridgeBio Pharma Affiliate Phoenix Tissue Repair Announces Positive Results from Phase 2 Trial of PTR-01, a Protein Replacement Therapy for the Treatment of Recessive Dystrophic Epidermolysis Bullosa - Yahoo Finance |
fool | 10 Amazing Stocks Under $10 |
yahoo | BridgeBio Pharma Presents Updated Results from Phase 2 Open-label Extension Study of Acoramidis in Transthyretin Amyloid Cardiomyopathy - Yahoo Finance |
fool | 3 Can't-Miss Biotech Events Coming Up in 2022 |